Cargando…

Dual inhibition of TMPRSS2 and Cathepsin Bprevents SARS-CoV-2 infection in iPS cells

It has been reported that many receptors and proteases are required for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Although angiotensin-converting enzyme 2 (ACE2) is the most important of these receptors, little is known about the contribution of other genes. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hashimoto, Rina, Sakamoto, Ayaka, Deguchi, Sayaka, Yi, Renxing, Sano, Emi, Hotta, Akitsu, Takahashi, Kazutoshi, Yamanaka, Shinya, Takayama, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527102/ https://www.ncbi.nlm.nih.gov/pubmed/34692233 http://dx.doi.org/10.1016/j.omtn.2021.10.016

Ejemplares similares

Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells
por: Sano, Emi, et al.
Publicado: (2021)

Exocyst complex component 2 is a potential host factor for SARS-CoV-2 infection
por: Yi, Renxing, et al.
Publicado: (2022)

Comparison of commercially available media for hepatic differentiation and hepatocyte maintenance
por: Toba, Yukiko, et al.
Publicado: (2020)

Elucidation of the liver pathophysiology of COVID-19 patients using liver-on-a-chips
por: Deguchi, Sayaka, et al.
Publicado: (2023)

State-of-the-art liver disease research using liver-on-a-chip
por: Deguchi, Sayaka, et al.
Publicado: (2022)

Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system
por: Takayama, Kazuo, et al.
Publicado: (2017)

iPS cell technologies: significance and applications to CNS regeneration and disease
por: Okano, Hideyuki, et al.
Publicado: (2014)

Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro
por: Tanaka, Akihito, et al.
Publicado: (2013)

Correction: Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro
por: Tanaka, Akihito, et al.
Publicado: (2013)

FGF signal is not required for hepatoblast differentiation of human iPS cells
por: Toba, Yukiko, et al.
Publicado: (2019)

Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
por: Kazuki, Yasuhiro, et al.
Publicado: (2009)

Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry
por: Shirato, Kazuya, et al.
Publicado: (2018)

Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells
por: Yamashita, Akihiro, et al.
Publicado: (2013)

Omicsynin B4 potently blocks coronavirus infection by inhibiting host proteases cathepsin L and TMPRSS2
por: Li, Yihua, et al.
Publicado: (2023)

Pluripotent stem cell-based therapies and their path to the clinic
por: Takayama, Kazuo, et al.
Publicado: (2023)

Expression dynamics of HAND1/2 in in vitro human cardiomyocyte differentiation
por: Okubo, Chikako, et al.
Publicado: (2021)

Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection
por: Padmanabhan, Pranesh, et al.
Publicado: (2020)

Generation of HepG2 Cells with High Expression of Multiple Drug-Metabolizing Enzymes for Drug Discovery Research Using a PITCh System
por: Negoro, Ryosuke, et al.
Publicado: (2022)

Determination of the interaction between the receptor binding domain of 2019-nCoV spike protein, TMPRSS2, cathepsin B and cathepsin L, and glycosidic and aglycon forms of some flavonols
por: İSTİFLİ, Erman Salih, et al.
Publicado: (2021)

Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
por: Yahata, Naoki, et al.
Publicado: (2011)

Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L
por: Prasad, Kartikay, et al.
Publicado: (2021)

Delivery of Full-Length Factor VIII Using a piggyBac Transposon Vector to Correct a Mouse Model of Hemophilia A
por: Matsui, Hideto, et al.
Publicado: (2014)

Cell response analysis in SARS-CoV-2 infected bronchial organoids
por: Sano, Emi, et al.
Publicado: (2022)

Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression
por: Gnirß, Kerstin, et al.
Publicado: (2012)

A disease-specific iPS cell resource for studying rare and intractable diseases
por: Saito, Megumu K., et al.
Publicado: (2023)

Genome Editing Gene Therapy for Duchenne Muscular Dystrophy
por: Hotta, Akitsu
Publicado: (2015)

Human iPS Cell–based Liver-like Tissue Engineering at Extrahepatic Sites in Mice as a New Cell Therapy for Hemophilia B
por: Okamoto, Ryota, et al.
Publicado: (2018)

Integration-Free iPS Cells Engineered Using Human Artificial Chromosome Vectors
por: Hiratsuka, Masaharu, et al.
Publicado: (2011)

Beyond iPS!
Publicado: (2012)

In Vitro Reconstruction of Neuronal Networks Derived from Human iPS Cells Using Microfabricated Devices
por: Takayama, Yuzo, et al.
Publicado: (2016)

Long-Term Self-Renewal of Human ES/iPS-Derived Hepatoblast-like Cells on Human Laminin 111-Coated Dishes
por: Takayama, Kazuo, et al.
Publicado: (2013)

Drug-Induced Naïve iPS Cells Exhibit Better Performance than Primed iPS Cells with Respect to the Ability to Differentiate into Pancreatic β-Cell Lineage
por: Kiyokawa, Yuki, et al.
Publicado: (2020)

Establishment of SLC15A1/PEPT1-Knockout Human-Induced Pluripotent Stem Cell Line for Intestinal Drug Absorption Studies
por: Kawai, Kanae, et al.
Publicado: (2019)

In Vitro Model for a Drug Assessment of Cytochrome P450 Family 3 Subfamily A Member 4 Substrates Using Human Induced Pluripotent Stem Cells and Genome Editing Technology
por: Deguchi, Sayaka, et al.
Publicado: (2021)

Interaction of certain monoterpenoid hydrocarbons with the receptor binding domain of 2019 novel coronavirus (2019-nCoV), transmembrane serine protease 2 (TMPRSS2), cathepsin B, and cathepsin L (CatB/L) and their pharmacokinetic properties
por: İSTİFLİ, Erman Salih, et al.
Publicado: (2020)

Biocompatible Films of Calcium Alginate Inactivate Enveloped Viruses Such as SARS-CoV-2
por: Cano-Vicent, Alba, et al.
Publicado: (2022)

Aging in iPS cells
por: Miller, Justine, et al.
Publicado: (2014)

SARS‐CoV‐2 research using human pluripotent stem cells and organoids
por: Deguchi, Sayaka, et al.
Publicado: (2021)

Generation of Tetrafluoroethylene–Propylene Elastomer-Based Microfluidic Devices for Drug Toxicity and Metabolism Studies
por: Sano, Emi, et al.
Publicado: (2021)

TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus
por: Sakai, Kouji, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_57an4qo7io9sg6sbe7ls1sovgn